UCL News


Statins’ potential to treat MS unrelated to lowering cholesterol

10 May 2019

A widely prescribed drug, simvastatin, can help patients with secondary progressive Multiple Sclerosis - for reasons that might be unrelated to the drug’s intended cholesterol lowering affects, finds a study led by Dr Arman Eshaghi (UCL Queen Square Institute of Neurology).

Read: TelegraphMore: UCL News